SERDA therapeutics
serda-therapeutics.com
Actively hiring
Wound Care
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
NLC Health Ventures
Momentum
0/100
no fresh signals
Tractionpublic signals, read monthly
Web presence
top 25%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
NLC Health Ventures Similar startupsby what they do, their industry and backers
Home. Rheumasense is actively developing its groundbreaking diagnostic technology for use in clinical studies, paving the way for FDA…
Sparrow Pharmaceuticals is an emerging clinical-stage biopharmaceutical company developing novel, targeted therapies for disorders of…
Latitude AI is a wholly owned subsidiary of Ford Motor Company that develops automated driving technologies. The company was formed in 2023…
Prevent the Preventable with Guardian Delivering unparalleled therapy that adapts to individual patient needs in real time to promote early…
LifeMine is a clinical-stage biopharmaceutical company pioneering a bold new approach, Top-Down Drug DiscoveryTM, which leverages…
Our technology-driven wound and ostomy services empower providers and help patients heal. Choose virtual or in-person support from our…
Overview
Company Company Innovative - Experienced - Growing. SERDA Therapeutics – a wholly owned subsidiary of Smith & Nephew – is a clinical-stage biopharmaceutical company developing a groundbreaking prescription product for fast and effective wound debridement.